As it turns out, some of the most amazing healing and regenerative tissue discovered to date resides exactly where our life begins; in the perinatal tissue (amniotic fluid, placental tissue, and Wharton's Jelly from the umbilical cord) all from healthy births. This tissue is donated and then rigorously tested and processed for regenerative use. Stem Cell Exosome Therapy is a customizable regenerative offering. We use Mesenchymal Stem Cell Exosomes, because they garner the best results for our patients. They contain the highest concentration of "Day 0" mesenchymal stem cells exosomes messengers and other growth factors that signal your cells to activate your own self-healing healing mechanisms, reduce inflammation and regenerate tissue. We work with the most sophisticated companies in the industry. These types of regenerative tissue products have been safely used for decades, but now it is specially packaged in an an “off the shelf” manner so we can inject for joint health and regeneration. Our patients report excellent results for joint pain, arthritis and many other conditions.
Are you a candidate? Click the button below to schedule an exam and consultation with one of our Nurse Practitioners.
Mesenchymal Stem Cell Exosomes from Perinatal Tissue
Not all stem cells are created equal. The Center for Wellbeing utilizes Mesenchymal Stem Cell Exosomes. These are the signals and healing messenger from the cells. There have three very important properties: they help reduce inflammation; modulate the immune system; and helps tissue to regenerate.
How Do They Work?
Stem cell exosomes have an innate intelligence and activate the body’s own self-healing mechanisms. They seek out inflammation and degeneration. In other words, they give your body a boost of fresh, “day 0”, stem cell exosomes (messengers) to help with regeneration. Our stem cells age with us and we lose a significant percentage over time. That's why we don't recover as quickly as we did in our younger years.
Safe and Regulated
The stem cell exosomes are procured and processed in the United States according to standards and regulations established by the American Association of Tissue Banks (AATB), the United States Food & Drug Administration (FDA). All local donors. Donor ethics and non-reactive FDA approved serological screening.
Amniotic fluid allografts have been FDA registered and processed in accordance with 21 CFR 1271 for “Homologous Use” to cover and protect tissues by providing cushioning, lubrication, and support.